Umb Bank, N.A. Xencor Inc Transaction History

Umb Bank, N.A.

$6.26 Billion
Q2 2025

A detailed history of Umb Bank, N.A. transactions in Xencor Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 553 shares of XNCR stock, worth $8,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares

553

Previous 376 47.07%

Holding current value

$8,333

Previous $2,000 100.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	BUY	$7.52 - $11.26 $1,331 - $1,993	177 Added 47.07%	553 $4,000
Q1 2025 Apr 14, 2025	BUY	$10.64 - $24.13 $2,542 - $5,767	239 Added 174.45%	376 $4,000
Q4 2024 Jan 16, 2025	BUY	$19.43 - $26.84 $155 - $214	8 Added 6.2%	137 $3,000
Q3 2024 Oct 08, 2024	BUY	$15.7 - $21.65 $1,020 - $1,407	65 Added 101.56%	129 $2,000
Q2 2024 Jul 29, 2024	BUY	$18.21 - $24.5 $764 - $1,029	42 Added 190.91%	64 $1,000
Q1 2024 Apr 26, 2024	BUY	$18.65 - $26.52 $410 - $583	22 New	22 $0
Q2 2023 Jul 25, 2023	BUY	$24.77 - $29.9 $990 - $1,196	40 New	40 $0

Others Institutions Holding XNCR

# of Institutions

205

Shares Held

81.9M

Call Options Held

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $900M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account